Triple G 4 mg vial
Delivery time
1-2 working days
quality assurance
Chemical reagent
CAS: 2381089-83-2
Price: 379,00 299.00 00zł
Retatrutyd Triple G – product characteristics
Retatrutyd Triple G It is a synthetic research peptide with a complex sequence structure, described in the scientific literature as a multi-receptor agonist of metabolic pathways. From a research perspective, its agonist profile with regard to receptors is of particular significance GLP-1, GIP and glucagon, which enables the assessment of the relationships between the activation of several receptor systems and the changes observed in metabolic models. In preclinical and clinical studies, Retatrutyd Triple G is being evaluated in the context of incretin signalling, glucose homeostasis, glucose-dependent insulinotropic response, lipid metabolism and the regulation of energy balance. The available scientific data describe retatrutyd as a molecule with a triple receptor profile, making it an interesting research model for studies into the pharmacology of metabolic peptides and incretin receptors. Compared with other peptides with a similar receptor profile, retatrutide is being investigated as a compound with a broader range of activity across metabolic pathways, which is the subject of further research.
Retatrutide peptide in receptor assays
Retatrutyd Triple G It is a synthetic research peptide being studied in the context of multi-receptor modulation of metabolic pathways. From a research perspective, its agonist profile with regard to receptors is of particular significance GLP-1, GIP and glucagon, which enables the assessment of the relationships between the activation of several signalling pathways and the body’s metabolic response. Unlike compounds that target a single receptor, retatrutide serves as a model for research into the complex regulation of glucose homeostasis, lipid metabolism and energy balance.
In receptor-based analyses, the GLP-1 pathway is primarily examined in relation to the regulation of glucose-dependent insulin secretion, the inhibition of glucagon signalling, and mechanisms involved in appetite control. The GIP pathway is studied in the context of the postprandial metabolic response, insulin secretion and interactions with GLP-1 signalling. Activity at the glucagon receptor, on the other hand, is analysed in studies on energy expenditure, lipid metabolism and the utilisation of energy substrates.
In scientific reports and clinical trials, a titration model was used to assess tolerance, safety and metabolic response as the concentration of the active substance was increased. Below you will find scientific sources and studies, together with the dosing regimens:
-Phase 2 studies: New England Journal of Medicine
-Escalation protocol : SIO Società Italiana Obesità
Scientific data: https://pubmed.ncbi.nlm.nih.gov/37366315/
All articles and information on this website are for informational and educational purposes only.
Specification:
Download the safety data sheet
| Parameter | Value |
|---|---|
| Product name | Triple G 4 mg vial |
| Catalogue number | 3862749-04-05 |
| CAS number | 2381089-83-2 |
| Brand | Novell |
| Category | Test compound/chemical reagent |
| Molecular target | GLP-1 / GIP / GCGR receptors |
| Sequence | modified research peptide; sequence as per batch specification / COA |
| Summary formula | C221H342N46O68 |
| Molar mass | approx. 4731.33 g/mol |
| Cleanliness | ≥99% HPLC / according to batch COA |
| Confirmation of identity | MS mass spectrometry / HPLC analysis / batch COA |
| Form | a clear solution in a vial |
| Unit quantity | Each vial contains 4 mg of the test compound. Quantity adapted for multiple laboratory tests and comparative analyses. |
| Concentration | according to batch / COA specifications |
| Buffer/Carrier | laboratory solution / carrier in accordance with the batch specification |
| pH of the solution | in accordance with the batch COA |
| Storage conditions | Store in a cool, dry, and dark place. Once opened, keep in the fridge and protect from light. |
| Stability after opening | according to laboratory protocol/batch COA |
| COA per batch | certificate of analysis available for each batch of product |
| Application | exclusively for laboratory tests, reference analyses and research-grade applications |
| Important information | This product is classified as a chemical reagent intended solely for scientific research, laboratory analysis and reference purposes. It is not a medicinal product, a food supplement or a foodstuff. It is not intended for use, administration or consumption by humans or animals, nor for diagnostic or therapeutic purposes. The purchaser is obliged to use the product in accordance with its intended purpose, applicable regulations and relevant laboratory procedures. The seller shall not be liable for the consequences of using the product contrary to its declared purpose, subject to mandatory provisions of law. |
14 day return policy
LAboratory quality
Safe shopping
Opinions
Novell – peptide reagents